» Articles » PMID: 16699312

IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Overview
Date 2006 May 16
PMID 16699312
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare B-cell lymphoma considered to be of germinal center (GC) derivation. Studies on immunoglobulin expression have been few, and post-switch immunoglobulin (IgG) has been identified in the majority of cases examined thus far. We reviewed 180 cases of NLPHL and observed the unexpected expression of IgD in 27% of cases. IgD is usually coexpressed with IgM in naive B cells but can also be seen as IgD-only in centroblasts (CD38-positive) or memory B cells (CD27-positive). We asked whether IgD-positive NLPHL differed from cases of NLPHL negative for IgD. Clinically, the IgD-positive cases presented at a younger median age (21 vs. 44 years) and had a striking male predominance (male-to-female ratio, 23:1 vs. 1.5:1). Cervical lymph nodes were more frequently involved (56% vs. 18.2%). L&H cells were localized in a predominantly extrafollicular distribution in the majority of IgD-positive cases (69%). The IgD-positive cases did not coexpress IgM or CD27 (a marker associated with memory B cells), and nearly all (93%) were weakly positive for CD38, supporting a GC derivation. The expression of Bcl-6, BOB.1, Oct2, and SWAP-70 was similar in the two groups. However, PU.1 expression was seen in 60% of the IgD-positive cases in contrast to 86% of the IgD-negative cases. The absence of PU.1 staining correlated with more L&H cells in an extrafollicular distribution, weakening the use of this marker in the differential diagnosis with T-cell rich/histiocyte rich B-cell lymphomas. To study IgD expression in "de-novo" T-cell rich/histiocyte rich B-cell lymphomas, we analyzed 20 cases and all but one were negative. In conclusion, cases of IgD-positive NLPHL do not differ from IgD-negative cases regarding cellular derivation and most other immunophenotypic characteristics. However, IgD-positive NLPHL exhibits distinctive clinical features, and more often involves the interfollicular region in a background relatively rich in T cells. IgD positivity may represent an additional useful marker in the diagnosis of NLPHL.

Citing Articles

Pediatric lymphomas: overview and diagnostic challenges.

Choi J, Quintanilla-Martinez L Virchows Arch. 2024; 486(1):81-100.

PMID: 39707053 PMC: 11782321. DOI: 10.1007/s00428-024-03980-9.


Histopathologic Features and Differential Diagnosis in Challenging Cases of Nodular Lymphocyte Predominant B-cell Lymphoma/Nodular Lymphocyte Predominant Hodgkin Lymphoma.

Ding Y, Jaffe E J Clin Transl Pathol. 2024; 4(2):61-69.

PMID: 39070246 PMC: 11271245. DOI: 10.14218/jctp.2024.00015.


B-cell receptor reactivity against in nodular lymphocyte-predominant Hodgkin lymphoma.

Thurner L, Fadle N, Regitz E, Roth S, Cetin O, Kos I Haematologica. 2023; 108(12):3347-3358.

PMID: 37139600 PMC: 10690923. DOI: 10.3324/haematol.2023.282698.


Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.

Takahara T, Satou A, Tsuzuki T, Nakamura S Diagnostics (Basel). 2022; 12(6).

PMID: 35741318 PMC: 9221773. DOI: 10.3390/diagnostics12061507.


3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma.

Sadeghi Shoreh Deli A, Scharf S, Steiner Y, Bein J, Hansmann M, Hartmann S Mod Pathol. 2022; 35(10):1431-1438.

PMID: 35173297 PMC: 9514992. DOI: 10.1038/s41379-022-01016-8.